EARNEST Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-47
Closed -$20.6K 664
2023
Q3
$20.6K Hold
47
﹤0.01% 493
2023
Q2
$23.6K Hold
47
﹤0.01% 453
2023
Q1
$23.5K Hold
47
﹤0.01% 450
2022
Q4
$19.2K Hold
47
﹤0.01% 491
2022
Q3
$15K Hold
47
﹤0.01% 507
2022
Q2
$16K Hold
47
﹤0.01% 500
2022
Q1
$26K Hold
47
﹤0.01% 436
2021
Q4
$31K Hold
47
﹤0.01% 410
2021
Q3
$29K Hold
47
﹤0.01% 412
2021
Q2
$30K Hold
47
﹤0.01% 406
2021
Q1
$23K Hold
47
﹤0.01% 439
2020
Q4
$23K Hold
47
﹤0.01% 419
2020
Q3
$18K Hold
47
﹤0.01% 429
2020
Q2
$16K Hold
47
﹤0.01% 447
2020
Q1
$11K Hold
47
﹤0.01% 483
2019
Q4
$12K Hold
47
﹤0.01% 553
2019
Q3
$13K Hold
47
﹤0.01% 521
2019
Q2
$13K Hold
47
﹤0.01% 520
2019
Q1
$11K Hold
47
﹤0.01% 552
2018
Q4
$9K Hold
47
﹤0.01% 567
2018
Q3
$12K Hold
47
﹤0.01% 534
2018
Q2
$10K Buy
47
+15
+47% +$3.09K ﹤0.01% 578
2018
Q1
$6K Hold
32
﹤0.01% 680
2017
Q4
$5K Buy
+32
New +$5.04K ﹤0.01% 739
2017
Q1
Sell
-32
Closed -$4K 548
2016
Q4
$4K Buy
+32
New +$3.65K ﹤0.01% 741

Other funds holding IDXX

EARNEST Partners's IDXX Position: Q4 2023 in Review

EARNEST Partners sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 47 shares — an estimated $20.6K sold.

EARNEST Partners first reported a position in IDXX in Q4 2016 and held it in 25 quarters. The position peaked at $31K in Q4 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • EARNEST Partners reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 47 Idexx Laboratories shares in Q4 2023, an estimated $20.6K.
  • EARNEST Partners first reported a position in Idexx Laboratories in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Idexx Laboratories position peaked at $31K in Q4 2021.
  • 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.